Skip to content

Clinical trials

Acquired Immunodeficiency Syndrome trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Not applicable Status: Unknown status Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20073
20083
20094
20112
20123
20136
20143
20151
20166
20179
20187
20199
20209
20215
20225
202310
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status94

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Guang'anmen Hospital of China Academy of Chinese Medical Sciences3
Karolinska Institutet3
McGill University3
Peking Union Medical College Hospital3
University of California, Los Angeles3
Hadassah Medical Organization2
Liverpool School of Tropical Medicine2
London School of Hygiene and Tropical Medicine2
Makerere University2
National Center for AIDS/STD Control and Prevention, China CDC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome94
HIV Infections16
Sexually Transmitted Diseases5
Infections3
Multiple Endocrine Neoplasia Type 13
Tuberculosis3
Hepatitis B2
Neoplasms2
Non-alcoholic Fatty Liver Disease2
Substance-Related Disorders2

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.